Lanzolla, G., Marinò, M. & Menconi, F. Graves disease: latest understanding of pathogenesis and treatment options. Nat. Rev. Endocrinol. 20, 647–660 (2024).

Article  CAS  PubMed  Google Scholar 

Long, S. A. & Buckner, J. H. Clinical and experimental treatment of type 1 diabetes. Clin. Exp. Immunol. 210, 105–113 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Tsokos, G. C. The immunology of systemic lupus erythematosus. Nat. Immunol. 25, 1332–1343 (2024).

Article  CAS  PubMed  Google Scholar 

Weyand, C. M. & Goronzy, J. J. The immunology of rheumatoid arthritis. Nat. Immunol. 22, 10–18 (2021).

Article  CAS  PubMed  Google Scholar 

Ashby, K. M. & Hogquist, K. A. A guide to thymic selection of T cells. Nat. Rev. Immunol. 24, 103–117 (2024).

Article  CAS  PubMed  Google Scholar 

Dikiy, S. & Rudensky, A. Y. Principles of regulatory T cell function. Immunity 56, 240–255 (2023).

Article  CAS  PubMed  Google Scholar 

Nemazee, D. Mechanisms of central tolerance for B cells. Nat. Rev. Immunol. 17, 281–294 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Freeborn, R. A., Strubbe, S. & Roncarolo, M. G. Type 1 regulatory T cell-mediated tolerance in health and disease. Front. Immunol. 13, 1032575 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petersone, L. et al. T Cell/B cell collaboration and autoimmunity: an intimate relationship. Front. Immunol. 9, 1941 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Ring, J. & Gutermuth, J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy 66, 713–724 (2011).

Article  CAS  PubMed  Google Scholar 

Durham, S. R. & Shamji, M. H. Allergen immunotherapy: past, present and future. Nat. Rev. Immunol. 23, 317–328 (2023).

Article  CAS  PubMed  Google Scholar 

Edwards, J. C. et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350, 2572–2581 (2004).

Article  CAS  PubMed  Google Scholar 

Garcia-Montoya, L., Villota-Eraso, C., Yusof, M. Y. M., Vital, E. M. & Emery, P. Lessons for rituximab therapy in patients with rheumatoid arthritis. Lancet Rheumatol. 2, e497–e509 (2020).

Article  PubMed  Google Scholar 

Hauser, S. L. et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358, 676–688 (2008).

Article  CAS  PubMed  Google Scholar 

Miloslavsky, E. M. et al. Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 66, 3151–3159 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stone, J. H. et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 363, 221–232 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mougiakakos, D. et al. CD19-targeted CAR T cells in refractory systemic lupus erythematosus. N. Engl. J. Med. 385, 567–569 (2021).

Article  PubMed  Google Scholar 

Müller, F. et al. CD19 CAR T-cell therapy in autoimmune disease – a case series with follow-up. N. Engl. J. Med. 390, 687–700 (2024).

Article  PubMed  Google Scholar 

Mackensen, A. et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat. Med. 28, 2124–2132 (2022).

Article  CAS  PubMed  Google Scholar 

Krickau, T. et al. CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis. Lancet 403, 1627–1630 (2024).

Article  CAS  PubMed  Google Scholar 

Kartnig, F. et al. Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls. Ann. Rheum. Dis. 82, 292–300 (2023).

Article  CAS  PubMed  Google Scholar 

Skapenko, A. & Schulze-Koops, H. COVID-19 vaccination in individuals with inflammatory rheumatic diseases. Nat. Rev. Rheumatol. 19, 76–77 (2023).

Article  PubMed  Google Scholar 

Stensland, Z. C., Cambier, J. C. & Smith, M. J. Therapeutic targeting of autoreactive B cells: why, how, and when? Biomedicines 9, 83 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Macauley, M. S. et al. Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. J. Clin. Invest. 123, 3074–3083 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Britanova, O. V. et al. Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis. Nat. Med. 29, 2731–2736 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benham, H. et al. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl. Med. 7, 290ra287 (2015).

Article  Google Scholar 

Bell, G. M. et al. Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Ann. Rheum. Dis. 76, 227–234 (2017).

Article  CAS  PubMed  Google Scholar 

Tang, T. T., Wang, B., Lv, L. L. & Liu, B. C. Extracellular vesicle-based nanotherapeutics: emerging frontiers in anti-inflammatory therapy. Theranostics 10, 8111–8129 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee, E. S. et al. Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis. Acta Biomater. 128, 462–473 (2021).

Article  CAS  PubMed  Google Scholar 

Lin, M. et al. Immunosuppressive microvesicles-mimetic derived from tolerant dendritic cells to target T-lymphocytes for inflammation diseases therapy. J. Nanobiotechnol. 22, 201 (2024).

Article  CAS  Google Scholar 

Serra, P. & Santamaria, P. Antigen-specific therapeutic approaches for autoimmunity. Nat. Biotechnol. 37, 238–251 (2019).

Article  CAS  PubMed  Google Scholar 

Bergot, A. S. et al. Regulatory T cells induced by single-peptide liposome immunotherapy suppress islet-specific T cell responses to multiple antigens and protect from autoimmune diabetes. J. Immunol. 204, 1787–1797 (2020).

Article  CAS  PubMed  Google Scholar 

Sonigra, A. et al. Randomized phase I trial of antigen-specific tolerizing imm